Our safety team of physicians and scientists are recognized experts both within and beyond AbbVie. In collaboration with academic scientists, health authorities and industry peers, we all actively advance the field of pharmaceutical safety. Our integrated, multi-disciplinary approach and advanced technologies are designed to identify potential safety signals early and minimize risk. We continually advance the knowledge, skills, and effectiveness of our safety teams, from those working on the drug development process, to those interacting with patients.

From our clinical trials to our marketed products, our practices reflect a deep commitment to patient safety:

• AbbVie was a leading adopter of the 2015 FDA Safety Assessment Committee recommendations for clinical trials, establishing an internal Safety Committee to advise and monitor two strategic clinical development programs.
•  We comply with the Good Clinical Practice, a global standard that helps assure the safety, integrity, and quality of trials across trial design, implementation, and outcomes reporting.
• Our product labeling and packaging is developed with patients’ needs in mind. We conduct in-depth research to understand patient preferences and behaviors to ensure that dosage instructions are clear to prevent accidental misuse. 
• We maintain a robust pharmacovigilance program once our medicines are approved and marketed. Our advanced post-marketing surveillance systems detect and address potential safety signals quickly.
• Our safety experts are leading thinkers in the field of Pharmacovigilance. They edited and made major contributions to the industry-shaping book, “Pharmacovigilance: A Practical Approach.”